Inventor · disambiguated record
Kam Fai Tse
Also filed as: TSE KAM FAI
6 granted patents·6 pending applications·78 citations·filing 2003–2017
84Inventor score
Technology areasA61P
Files withCELLDEX THERAPEUTICS INC5JANSSEN BIOTECH INC2LANDES GREGORY M2ALMAGRO JUAN CARLOS1XIAO FENG1
Top patents by PatentIndex Score
12 records- 0189US8951525B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2013·Granted Feb 10, 2015·11 cites·17 claims
- 0289US8722044B2Human tissue factor antibody and uses thereofALMAGRO JUAN CARLOS·Filed 2012·Granted May 13, 2014·12 cites·19 claims
- 0388US8999333B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2014·Granted Apr 7, 2015·9 cites·15 claims
- 0487US8067544B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2004·Granted Nov 29, 2011·37 cites·18 claims
- 0580US8846873B2Antibodies directed to GPNMB and uses thereofXIAO FENG·Filed 2012·Granted Sep 30, 2014·9 cites·27 claims
- 0655US2015044212A1Antibodies Directed to GPNMB and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0750US2017218067A1Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0849US9580503B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2011·Granted Feb 28, 2017·0 cites·16 claims
- 0947US2016311919A1Antibodies Directed To GPNMB And Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1047US2013202527A1Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain And Mucin Domain 1 (TIM-1) AntigenCELLDEX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1144US2017267750A1Method of Treating Ovarian and Renal Cancer Using Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) AntigenCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1237US2005014687A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →